Suppr超能文献

七氟醚与丙泊酚用于减少非心脏手术患者围术期心肌缺血的随机比较。

Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery.

机构信息

Department of Anesthesia and Intensive Care Medicine, University Hospital Basel, Spitalstrasse 21, CH-4031 Basel, Switzerland.

出版信息

Circulation. 2012 Dec 4;126(23):2696-704. doi: 10.1161/CIRCULATIONAHA.112.126144. Epub 2012 Nov 7.

Abstract

BACKGROUND

Volatile anesthetics provide myocardial preconditioning in coronary surgery patients. We hypothesized that sevoflurane compared with propofol reduces the incidence of myocardial ischemia in patients undergoing major noncardiac surgery.

METHODS AND RESULTS

We enrolled 385 patients at cardiovascular risk in 3 centers. Patients were randomized to maintenance of anesthesia with sevoflurane or propofol. We recorded continuous ECG for 48 hours perioperatively, measured troponin T and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) on postoperative days 1 and 2, and evaluated postoperative delirium by the Confusion Assessment Method. At 6 and 12 months, we contacted patients by telephone to assess major adverse cardiac events. The primary end point was a composite of myocardial ischemia detected by continuous ECG and/or troponin elevation. Additional end points were postoperative NT-proBNP concentrations, major adverse cardiac events, and delirium. Patients and outcome assessors were blinded. We tested dichotomous end points by χ(2) test and NT-proBNP by Mann-Whitney test on an intention-to-treat basis. Myocardial ischemia occurred in 75 patients (40.8%) in the sevoflurane and 81 (40.3%) in the propofol group (relative risk, 1.01; 95% confidence interval, 0.78-1.30). NT-proBNP release did not differ across allocation on postoperative day 1 or 2. Within 12 months, 14 patients (7.6%) suffered a major adverse cardiac event after sevoflurane and 17 (8.5%) after propofol (relative risk, 0.90; 95% confidence interval, 0.44-1.83). The incidence of delirium did not differ (11.4% versus 14.4%; P=0.379).

CONCLUSIONS

Compared with propofol, sevoflurane did not reduce the incidence of myocardial ischemia in high-risk patients undergoing major noncardiac surgery. The sevoflurane and propofol groups did not differ in postoperative NT-proBNP release, major adverse cardiac events at 1 year, or delirium.

摘要

背景

挥发性麻醉剂可为冠状动脉手术患者提供心肌预处理。我们假设七氟醚与丙泊酚相比可降低行非心脏大手术患者的心肌缺血发生率。

方法和结果

我们在 3 家中心招募了 385 名心血管风险患者。患者被随机分配接受七氟醚或丙泊酚维持麻醉。我们在围手术期连续记录 48 小时心电图,在术后第 1 天和第 2 天测量肌钙蛋白 T 和脑钠肽前体(NT-proBNP),并通过意识混乱评估方法评估术后谵妄。在 6 个月和 12 个月时,我们通过电话联系患者评估主要不良心脏事件。主要终点是连续心电图和/或肌钙蛋白升高检测到的心肌缺血复合终点。其他终点包括术后 NT-proBNP 浓度、主要不良心脏事件和谵妄。患者和结局评估者设盲。我们基于意向治疗原则通过卡方检验检验二分类结局,通过 Mann-Whitney 检验检验 NT-proBNP。七氟醚组有 75 例(40.8%)和丙泊酚组有 81 例(40.3%)患者发生心肌缺血(相对风险,1.01;95%置信区间,0.78-1.30)。术后第 1 天或第 2 天两组间 NT-proBNP 释放无差异。在 12 个月内,七氟醚组有 14 例(7.6%)和丙泊酚组有 17 例(8.5%)患者发生主要不良心脏事件(相对风险,0.90;95%置信区间,0.44-1.83)。谵妄发生率无差异(11.4%比 14.4%;P=0.379)。

结论

与丙泊酚相比,高危行非心脏大手术患者中,七氟醚并未降低心肌缺血发生率。七氟醚组和丙泊酚组在术后 NT-proBNP 释放、1 年时主要不良心脏事件或谵妄方面无差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验